11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
In 2019, the New York State Legislature made substantial changes to workplace laws. It seems likely ...
Read More >
Illinois employers must begin preparing now for the host of new legal requirements impacting the wor...
Read More >
The National Labor Relations Board (NLRB or Board) issued a decision on June 14, reversing nearly 40...
Read More >
The U.S. Renewable Energy Industry, including its construction market, like every sector of the econ...
Read More >
Yesterday, US Immigration and Customs Enforcement, or ICE, raided several poultry and food processin...
Read More >
To provide another opportunity to receive input on the Agency’s proposed revisions to the EEO-1 rep...
Read More >